Viewing Study NCT02465606


Ignite Creation Date: 2025-12-26 @ 2:42 PM
Ignite Modification Date: 2026-03-01 @ 7:58 AM
Study NCT ID: NCT02465606
Status: COMPLETED
Last Update Posted: 2020-01-27
First Post: 2015-06-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module